NEUROTROPE BIOSCIENCE, INC. Business Operations Contracts & Agreements
7 Contracts & Agreements
- Agency Agreements (1 contract)
- Collaboration Agreements (1)
- Indemnification Agreements (1)
- Services Agreements (4)
- Collaboration Agreement, dated October 31, 2023, by and between Synaptogenix, Inc. and Cannasoul Analytics Ltd (Filed With SEC on November 6, 2023)
- Master Services Agreement, between Synaptogenix, Inc. and Worldwide Clinical Trials, Inc., dated as of February 7, 2022 and Work Order, dated May 12, 2022 (Filed With SEC on August 5, 2022)
- Services Agreement by and between Neurotrope, Inc. and Worldwide Clinical Trials, Inc., dated as of May 4, 2018 (assumed by Synaptogenix, Inc. on December 7, 2020) (Filed With SEC on March 30, 2021)
- Services Agreement between Neurotrope BioScience, Inc. and Worldwide Clinical Trials, Inc., dated October 9, 2015 (Filed With SEC on March 30, 2021)
- Form of Director Indemnification Agreement (Filed With SEC on March 30, 2021)
- Placement Agency Agreement, dated January 21, 2021, by and between Synaptogenix, Inc., and GP Nurmenkari Inc (Filed With SEC on January 22, 2021)
- Services Agreement between Neurotrope BioScience, Inc. and Worldwide Clinical Trials, Inc., dated July 23, 2020 (Filed With SEC on October 9, 2020)
